Tarsus Advances Eye Care Leadership Strategy with Acquisition of iRenix Medical and Late-Stage Asset IRX-101IRX-101 addresses a pressing issue for millions of individuals experiencing vision impairment. This innovative solution has the capacity to enhance the quality of treatment for these patients.
